Study of the mechanism of lung vascular permeability in pulmonary edema
肺血管通透性在肺水肿中的作用机制研究
基本信息
- 批准号:09470325
- 负责人:
- 金额:$ 9.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
A variety of chemical mediators has been known to be responsible for the development of permeability pulmonary edema. We have been investigating the mechanisms of neurogenic pulmonary edema by using a rat model in which fibrinogen and thrombin are injected into the cisterna magna (neurogenic pulmonary edema model), and have found that neuropeptide Y (NPY) and neurokinin A, simultaneously released from the sympathetic nerve terminal, increase pulmonary vascular permeability. In terms of NPY, we reported a pioneer work in which NPY is proved to be one of the permeability substances by using an isolated perfused lung model and stimulating the sympathetic nerve. We also clarified that NPY administered intratracheally increases lung vascular permeability dose-despondently in the same model. In the following study, we have found that NPY is present both in the edema fluid and in alveolar macrophages and the concentration is 1000 times higher than that found in plasma by using an immunohistochemical method.In the present study, we have meticulously studied the effect of nitric oxide (NO) on the development of pulmonary edema. The present results may suggest that the mechanism of neurogenic pulmonary edema is peripherally related to the release of chemical mediators such as NPY from the sympathetic nerve terminal, and centrally related to NO in the central nervous system. Also in a preliminary study of rats in which the vagus nerve was severed several days before, neurogenic pulmonary edema was completely avoided. Although the precise mechanism is still not clear, the development of neurogenic pulmonary edema may be closely related to the effects of NO in the central nervous system and NPY in the peripheral sympathetic nerve terminal.
各种化学介质已被认为是负责的渗透性肺水肿的发展。我们一直在研究神经源性肺水肿的机制,通过使用大鼠模型,其中纤维蛋白原和凝血酶被注射到小脑延髓池(神经源性肺水肿模型),并发现神经肽Y(NPY)和神经激肽A,同时从交感神经末梢释放,增加肺血管通透性。在神经肽Y方面,我们报道了一个开创性的工作,其中通过使用离体灌流肺模型和刺激交感神经证实了神经肽Y是渗透性物质之一。我们还阐明,在同一模型中,血管内给予NPY可剂量依赖性地增加肺血管通透性。本研究采用免疫组织化学方法,发现肺水肿液和肺泡巨噬细胞中均存在NPY,其浓度比血浆中高1000倍,并详细研究了一氧化氮(NO)在肺水肿发生发展中的作用。提示神经源性肺水肿的发病机制可能与交感神经末梢释放NPY等化学介质有关,而与中枢NO有关。此外,在对大鼠的初步研究中,迷走神经在几天前被切断,神经源性肺水肿完全避免。虽然确切的机制尚不清楚,但神经源性肺水肿的发生可能与中枢神经系统NO和外周交感神经末梢NPY的作用密切相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yamashita, A: "Effects of neuropeptide Y on pulmonary vascular permeability and its receptor subtype in rats"11th World Congress of Anaesthesiologists, Abstract Book. 246. (1996)
Yamashita,A:“神经肽 Y 对大鼠肺血管通透性及其受体亚型的影响”第 11 届世界麻醉医师大会,摘要书。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
藤原祥裕: "Transfer function analysis of the circulation in patients undergoing sevoflurane anesthesia"Can J Anesth. 46. 820-825 (1999)
Yoshihiro Fujiwara:“接受七氟醚麻醉的患者循环的传递函数分析”Can J Anesth 46. 820-825 (1999)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kimura, T: "Heart rate and blood pressure power spectral analysis during calcium channel blocker induced hypotension"Canadian Journal of Anesthesia. 46. 1110-1116 (1999)
Kimura, T:“钙通道阻滞剂引起的低血压期间的心率和血压功率谱分析”加拿大麻醉杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
木村智政: "Heart rate and blood pressure power spectral analysis during calcium channel blocker induced hypotension"Can J Anesth. 46. 1110-1116 (1999)
Tomomasa Kimura:“钙通道阻滞剂引起的低血压期间的心率和血压功率谱分析”Can J Anesth. 46. 1110-1116 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ishikawa, N: "Contribution of cytosolic ionic and energetic milieu changes to ischemia- and reperfusion-induced injury in guinea pig heart : fluorometry and nuclear magnetic resonance studies"Journal of Cardiovascular Pharmacology. 31. 146-156 (1998)
Ishikawa,N:“细胞质离子和能量环境变化对豚鼠心脏缺血和再灌注诱导损伤的贡献:荧光测定和核磁共振研究”心血管药理学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHIMADA Yasuhiro其他文献
SHIMADA Yasuhiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHIMADA Yasuhiro', 18)}}的其他基金
Mechanisms of increased vascular permeability associated with sympathetic excitability and the development of treatment strategy of ARDS.
血管通透性增加与交感神经兴奋相关的机制及ARDS治疗策略的制定。
- 批准号:
16390448 - 财政年份:2004
- 资助金额:
$ 9.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study on the Neural Network relating to Pulmonary Vascular Permeability and Cloning of its Receptor
肺血管通透性相关神经网络及其受体克隆的研究
- 批准号:
12470318 - 财政年份:2000
- 资助金额:
$ 9.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study on the Mechanism of Increased Vascular Permeability in Pulmonary Edema
肺水肿血管通透性增加的机制研究
- 批准号:
06454443 - 财政年份:1994
- 资助金额:
$ 9.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Inhalation anesthetics and oncogene
吸入麻醉剂和癌基因
- 批准号:
01440063 - 财政年份:1989
- 资助金额:
$ 9.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (A)
Mechanism and the Effects of Anesthetics and Anesthetic Depth on the Development of Neurogenic Pulmonary Edema.
麻醉药和麻醉深度对神经源性肺水肿发生的机制和影响。
- 批准号:
61480332 - 财政年份:1986
- 资助金额:
$ 9.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
- 批准号:82372007
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
- 批准号:82371997
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
IL-33调控EOMES+Tr1样细胞分化介导EGFR突变肺癌免疫逃逸的机制研究
- 批准号:n/a
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
- 批准号:82372203
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
(11)C标记tariquidar及表达P-糖蛋白的耐药性肺癌PET显像
- 批准号:81101776
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
非吸烟肺癌表皮生长因子受体基因相关非编码小RNA差异表达研究
- 批准号:81071914
- 批准年份:2010
- 资助金额:36.0 万元
- 项目类别:面上项目
肢体缺血后适应抑制肺泡巨噬细胞活化及防治肺缺血再灌注损伤机制的研究
- 批准号:81070041
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
常山酮增强肺癌放疗效果同时预防放射性肺损伤的分子机制研究
- 批准号:30970864
- 批准年份:2009
- 资助金额:29.0 万元
- 项目类别:面上项目
Endoglin基因修饰肿瘤/DC杂交细胞诱生靶向特异性抗人肺癌CTL疫苗的研究
- 批准号:30760248
- 批准年份:2007
- 资助金额:16.0 万元
- 项目类别:地区科学基金项目
与肺癌细胞侵袭相关的microRNAs研究
- 批准号:30771187
- 批准年份:2007
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Invovlvement of increased vascular permeability in bortezomib-induced lung toxicity
血管通透性增加参与硼替佐米诱导的肺毒性
- 批准号:
21K06703 - 财政年份:2021
- 资助金额:
$ 9.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role and regulation of vascular permeability in pulmonary fibrosis
血管通透性在肺纤维化中的作用和调节
- 批准号:
9756465 - 财政年份:2018
- 资助金额:
$ 9.34万 - 项目类别:
Role and regulation of vascular permeability in pulmonary fibrosis
血管通透性在肺纤维化中的作用和调节
- 批准号:
10223415 - 财政年份:2018
- 资助金额:
$ 9.34万 - 项目类别:
Regulation of Endothelial-Neutrophil Interaction and Lung Vascular Permeability in Sepsis
脓毒症中内皮-中性粒细胞相互作用和肺血管通透性的调节
- 批准号:
9788499 - 财政年份:2018
- 资助金额:
$ 9.34万 - 项目类别:
Regulation of Endothelial-Neutrophil Interaction and Lung Vascular Permeability in Sepsis
脓毒症中内皮-中性粒细胞相互作用和肺血管通透性的调节
- 批准号:
10004113 - 财政年份:2018
- 资助金额:
$ 9.34万 - 项目类别:
Role and regulation of vascular permeability in pulmonary fibrosis
血管通透性在肺纤维化中的作用和调节
- 批准号:
10457937 - 财政年份:2018
- 资助金额:
$ 9.34万 - 项目类别:
Regulation of lung vascular permeability by lysosomal trafficking
溶酶体运输调节肺血管通透性
- 批准号:
326606907 - 财政年份:2017
- 资助金额:
$ 9.34万 - 项目类别:
Research Grants
Crosstalk between S1P Receptor 1/S1P1 and P-Selectin/Selp in Regulation of Inflammatory Vascular Permeability
S1P 受体 1/S1P1 和 P-选择素/Selp 之间的串扰调节炎症血管通透性
- 批准号:
10871784 - 财政年份:2016
- 资助金额:
$ 9.34万 - 项目类别:
Cortactin in Regulation of Pulmonary Vascular Permeability
Cortactin 调节肺血管通透性
- 批准号:
9130397 - 财政年份:2015
- 资助金额:
$ 9.34万 - 项目类别:
Modulation of Pulmonary Vascular Permeability and Inflammation by Mesenchymal Stem Cells (MSCs) in Hemorrhagic Shock
失血性休克中间充质干细胞 (MSC) 对肺血管通透性和炎症的调节
- 批准号:
9144825 - 财政年份:2015
- 资助金额:
$ 9.34万 - 项目类别: